P-gp Transporter and its Role in Neurodegenerative Diseases

Author(s): Simona Rapposelli, Maria Digiacomo, Aldo Balsamo

Journal Name: Current Topics in Medicinal Chemistry

Volume 9 , Issue 2 , 2009

Become EABM
Become Reviewer
Call for Editor


This paper describes an overview of recent insights concerning some socially relevant neurodegenerative diseases such as Alzheimers (AD), Parkinsons (PD), Huntingtons (HD) and Creutzfeldt-Jakobs (CJD) diseases, amyotrophic lateral sclerosis (ALS) and epilepsy. For each pathological state, the direct and/or indirect involvement of Pglycoprotein (P-gp) efflux transport is underlined. On this basis, P-gp still represents an innovative target which can offer new tools for the development of more effective and preventive therapeutic strategies for neurodegenerative disorders. For each of them, therefore, a possible use of drugs affecting P-gp transport activity has been suggested.

Keywords: P-glycoprotein, Neurodegenerative disorder, Epilepsy, Alzheimer, Parkinson, Hungtington, ALS

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [209 - 217]
Pages: 9
DOI: 10.2174/156802609787521544
Price: $65

Article Metrics

PDF: 10